| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/17/2008 | US20080090806 (Calcitonin gene related peptide); azepinone ligands; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide; analgesic, antiinflammatory agent; migranes, arthritis, neurodegenerative diseases |
| 04/17/2008 | US20080090801 2-amino-8-(trans-4-hydroxycyclohexyl)-4-methyl-7-oxo-N-1H-pyrazol-5-yl-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxamide; anticarcinogenic; phosphoinositide 3-kinase alpha (PI3-K alpha ) inhibitor; cell cycle regulation, proliferation, apoptosis; inhibit resistance to cytotoxic agents in cancer cells |
| 04/17/2008 | US20080090798 Heterocyclic Substituted Aminoazacycles Useful as Central Nervous System Agents |
| 04/17/2008 | US20080090771 Modification of pharmacokinetic and pharmacological properties of hydrocodone through covalent modification by conjugating hydrocodone with a carrier selected from an amino acid, a dipeptide, a tripeptide, a tetrapeptide and a pentapeptide; analgesic; bioavailability |
| 04/17/2008 | US20080090325 Method for producing organic field-effect transistors |
| 04/17/2008 | US20080089858 Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism |
| 04/17/2008 | US20080087878 Use of perylene diimide derivatives as air-stable n-channel organic semiconductors |
| 04/17/2008 | DE102006048728A1 3-Amino-imidazo{1,2-a]pyridinderivate 3-amino-imidazo {1,2-a] pyridine |
| 04/17/2008 | CA2675511A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | CA2666658A1 Chymase inhibitors |
| 04/17/2008 | CA2666143A1 Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain |
| 04/17/2008 | CA2666130A1 Kinase inhibitors |
| 04/16/2008 | EP1911759A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 04/16/2008 | EP1911753A1 Spiro-cyclic compound |
| 04/16/2008 | EP1910377A2 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 04/16/2008 | EP1910376A1 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 04/16/2008 | EP1910366A2 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them |
| 04/16/2008 | EP1910365A2 Inhibitors of checkpoint kinases |
| 04/16/2008 | EP1910364A2 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/16/2008 | EP1910363A2 Hiv integrase inhibitors |
| 04/16/2008 | EP1910361A2 Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists |
| 04/16/2008 | EP1910360A2 Hiv reverse transcriptase inhibitors |
| 04/16/2008 | EP1910359A1 PYRIDO [2 , 3-D]PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS |
| 04/16/2008 | EP1910358A2 Heterocyclic janus kinase 3 inhibitors |
| 04/16/2008 | EP1910357A2 Indoli zine derivatives and their use as crth2 antagonists |
| 04/16/2008 | EP1910356A2 Hiv integrase inhibitors |
| 04/16/2008 | EP1910355A2 Hiv integrase inhibitors |
| 04/16/2008 | EP1910312A1 Quadratic acid ii derivatives |
| 04/16/2008 | EP1910293A1 Isotopically substituted proton pump inhibitors |
| 04/16/2008 | EP1909792A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 04/16/2008 | EP1909791A1 G-protein coupled receptor agonists |
| 04/16/2008 | EP1909788A2 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 04/16/2008 | CN101163704A Tadalafil having a large particle size and a process for preparation thereof |
| 04/16/2008 | CN101163703A Imidazo [1, 2-a]pyridine derivatives useful as peptide deformylase (pdf) inhibitors |
| 04/16/2008 | CN101163702A Preparation of aseptic 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4h-pyridio[1,2-a]pyrimidin-4-one palmitate ester |
| 04/16/2008 | CN101163700A 三胺衍生物 Triamine derivative |
| 04/16/2008 | CN101163475A 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381936C Linked dihydrazone-based charge transport compounds |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/15/2008 | USRE40245 Gyrase inhibitors and uses thereof |
| 04/15/2008 | US7358365 Process for the controlled increase in the molecular weight of polyethylenes |
| 04/15/2008 | US7358364 Substituted carboxylic acids |
| 04/15/2008 | US7358363 Zinc complexes capable of capturing substances having anionic substituents |
| 04/15/2008 | US7358362 Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis |
| 04/15/2008 | US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/15/2008 | US7358259 Tetrazoloquinoline, triazoloquinoline, and oxazoloquinoline compounds, e.g., 9-chloro-N-isopropoxytetrazolo[1,5-a]quinoline-4-carboxamide |
| 04/15/2008 | US7358249 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/15/2008 | US7358243 1-[9-(3-Phenyl-allyl)-3,9 diaza-bicyclo[4.2.1]non-3-yl]-propan-1-one; analgesic; great selectivity to mu receptor; analgesic; pain relief, drug dependence, alcoholism; side effect reduction |
| 04/15/2008 | US7358242 N-benzyl-2-[4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-2,3,6,10b-tetraaza-benzo[e]azulen-6-yl]-N-isopropyl-acetamide; cholecystokinin-A (CCK-A) receptor agonist; antidiabetic; obesity |
| 04/15/2008 | US7358238 3-(2-Phenoxymethyl-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]azepin-9-one; inhibiting the activity of 11 beta -hydroxysteroid dehydrogenase type 1 (11 beta HSD1); increase intracellular concentration of active glucocorticoid; metabolic disorders, insulin resistance, dyslipidemia, obesity |
| 04/15/2008 | US7358235 Nitrobenzylthioinosine compounds for relief of pain |
| 04/15/2008 | US7357881 Cycloamide-transition metal complexes and bleach catalysts |
| 04/10/2008 | WO2008043087A2 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
| 04/10/2008 | WO2008041331A1 Fluorescent rare-earth-metal complex |
| 04/10/2008 | WO2008041118A2 Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| 04/10/2008 | WO2008041037A1 Fused indoles and indazoles as inhibitors of poly(adp-ribose)polymerase (parp) |
| 04/10/2008 | WO2008040820A2 Fungicidal n-heteroaryl-condensed pyridine derivatives and fungicidal compositions |
| 04/10/2008 | WO2008021346A3 Pure paliperidone and processes for preparing thereof |
| 04/10/2008 | WO2008016547A3 Aurora kinase inhibitors from an encoded small molecule library |
| 04/10/2008 | WO2007149451B1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 04/10/2008 | WO2007110868A3 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 04/10/2008 | WO2007107345A3 PROCESS FOR PREPARING l-HALO-2,7-NAPHTHYRIDINYL DERIVATIVES |
| 04/10/2008 | WO2007003525A3 Cyclic anilino-pyridinotriazines as gsk-3 inhibitors |
| 04/10/2008 | US20080085913 Polymorphic Forms of a Gabaa Agonist |
| 04/10/2008 | US20080085901 Heteroaryl Substituted Quinolin-4-Ylamine Analogues |
| 04/10/2008 | US20080085896 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 04/10/2008 | US20080085887 Hypoparathyroidism, osteoporosis, osteopenia, periodontal disease, Paget's disease, bone fracture, osteoarthritis, rheumatoid arthritis, and humoral hypercalcemia of malignancy; e.g. (R)-3-(1-(3,4-difluorophenyl) propan-2-yl)-2-(3-hydroxypyridin-2-yl) 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one |
| 04/10/2008 | US20080085886 Anticancer and/or antiinflammatory activity, MEK (MAP kinase kinase) inhibitors; for example, 3-(2-Fluoro-4-iodo-phenylamino)-furo[3,2-c]pyridine-2-carboxylic acid ((R)-2,3-dihydroxy-propoxy)-amide |
| 04/10/2008 | CA2663436A1 Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| 04/09/2008 | EP1908763A1 Bicyclic compounds |
| 04/09/2008 | EP1907484A1 Naphthalene amidine imides |
| 04/09/2008 | EP1907394A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 04/09/2008 | EP1907390A2 Diazepinoquinolines, synthesis thereof, and intermediates thereto |
| 04/09/2008 | EP1907389A2 Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
| 04/09/2008 | EP1907388A1 Novel heteroaryl fused cyclic amines |
| 04/09/2008 | EP1907384A2 Gpcr agonists |
| 04/09/2008 | EP1907372A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 04/09/2008 | EP1907362A1 Amide derivatives as kinase inhibitors |
| 04/09/2008 | EP1907361A1 Amide derivatives as kinase inhibitors |
| 04/09/2008 | EP1906958A2 Pyrazolo[3,4-b]pyridin-2-yl]-benzoic acid derivatives as hiv integrase inhibitors |
| 04/09/2008 | EP1906953A1 Acid and base salt forms of gaboxadol |
| 04/09/2008 | EP1725415B1 Steering and driving system for an industrial truck |
| 04/09/2008 | EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials |
| 04/09/2008 | EP0964864B1 Pyrido 2,3-d pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation |
| 04/09/2008 | CN101160309A Novel imidazo [1, 5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/09/2008 | CN101160308A Methods of treating cancer and related methods |
| 04/09/2008 | CN101160286A Process for the preparation of ccr-2 antagonist |
| 04/09/2008 | CN101157694A Carboline compound, application and preparation method thereof |
| 04/09/2008 | CN100379744C The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 04/09/2008 | CN100379742C New tricyclic derivatives as LTD4 antagonists |
| 04/09/2008 | CN100379735C 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents |
| 04/09/2008 | CN100379734C Azaindoles |
| 04/09/2008 | CN100379421C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/08/2008 | US7355775 Photochromic diarylethene-containing coordination compounds and the production thereof |
| 04/08/2008 | US7355046 Chronic obstructive pulmonary dusease; asthma |
| 04/08/2008 | US7355040 Process for the preparation of cephalosporin compounds and synthetic intermediates |
| 04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 04/08/2008 | US7354932 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/08/2008 | US7354929 6-benzyl-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-2,6-dihydropyrazolo[3,4-c]pyridin-7-one; eating and psychological disorders; obesity, alcoholism |